Boyce J R, Cervenko F W, Wright F J
Can Anaesth Soc J. 1978 Jul;25(4):323-8. doi: 10.1007/BF03005657.
Following the production of digitalis toxicity in dogs as manifested by ventricular tachycardia, the pharmacokinetics of lidocaine treatment of the arrhythmia were determined during pentobarbitone anaesthesia and pentobarbitone-halothane anaesthesia. The elimination rate constants, beta and Ke, and the biological half life T1/2beta were statistically significantly increased during halothane anaesthesia. The volume of distribution was unchanged. The results indicate that the therapeutic loading dose of lidocaine need not be altered during halothane anaesthesia but if a constant infusion is used, the rate of infusion would have to be decreased four fold to avoid toxic plasma levels of lidocaine.
在犬产生洋地黄毒性并表现为室性心动过速后,于戊巴比妥麻醉和戊巴比妥 - 氟烷麻醉期间测定利多卡因治疗心律失常的药代动力学。在氟烷麻醉期间,消除速率常数β和Ke以及生物半衰期T1/2β在统计学上显著增加。分布容积未改变。结果表明,在氟烷麻醉期间利多卡因的治疗负荷剂量无需改变,但如果采用持续输注,则输注速率必须降低四倍以避免利多卡因血浆中毒水平。